Advertisement


Aurobindo Pharma
Business  /  Published 29.03.22

Aurobindo to buy Veritaz biz

Hyderabad-based Aurobindo Pharma on Monday said it will acquire the branded generic business of Veritaz for Rs 171 crore in cash. Veritaz is a 100 per cent subsidiary of Trident Chemphar and it poste...
By Our Special Correspondent in Mumbai

India  /  Published 24.12.20

Aurobindo Pharma enters vaccine market

Aurobindo Pharma on Thursday said it has inked a licensing pact with US-based company COVAXX to develop and commercialise a vaccine for Covid-19. The company has entered an exclusive licence agreemen...
By Our Bureau, Agencies in New Delhi

Business  /  Published 18.11.20

Pfizer to sue Indian drug duo

Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma and Dr Reddy’s Laboratories alleging that the Indian drug makers were planning separately to come out w...
By PTI in Hyderabad

Business  /  Published 22.09.19

Dr. Reddy's halts global supply of ranitidine

Dr Reddy's Laboratories Limited on Sunday said that it is suspending supply of its drug ranitidine worldwide as a precautionary measure, following the ongoing probe by the US Food and Drug Administrat...
By PTI in Hyderabad

Business  /  Published 02.04.20

Covid-19 blow to Aurobindo Pharma

Hyderabad-based Aurobindo Pharma on Thursday said its $900 million deal to acquire Sandoz Inc’s generic oral solids and dermatology businesses in the US has been mutually called off in the absence o...
By Our Special Correspondent in Mumbai

Business  /  Published 14.05.19

Pharmaceutical duo vow to fight price fix charge

Drug majors Aurobindo Pharma and Dr Reddy’s Laboratories on Tuesday said they were preparing their legal defence to the charges of price fixing in the US market.As many as 49 US states have filed pr...
By Our Special Correspondent in Mumbai


Advertisement

Download our latest App

to get update on the go...


Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.